In this study, the bioinformatical analysis, in combination with molecular study, showed that the activation of JNK1/2 and p38 was inhibited by LAPTM5 overexpression but enhanced by LAPTM5 deletion in NASH models. This evidence concerns the gene LAPTM5 and metabolic dysfunction-associated steatohepatitis.